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Abstract.  The ontogeny of t~-fetoprotein  (AFP) gene 
expression has been examined in the fetal and adult 
mouse gastrointestinal  tract.  AFP mRNA constitutes 
•0.1%  of total mRNA in the fetal gut.  The transcripts 
were localized by in situ hybridization to the epithelial 
cells lining the villi of the fetal gut.  At birth,  AFP 
mRNA declines rapidly to achieve low adult basal lev- 
els, which are not affected by different alleles of raf,  a 
gene that determines the adult basal level of AFP 
mRNA in the liver.  The basal level in the adult gut is 
the consequence of continued AFP transcription  in a 
small number of enteroendocrine cells that are distrib- 
uted infrequently on the villi.  These cells were 
identified by double antibody staining  with antibodies 
to chromogranin  A, an enteroendocrine cell marker 
and AFP. Previous studies resulted in the generation 
of a line of transgenic mice containing  an internally 
deleted AFP gene that was greatly overexpressed in 
the fetal gut.  The basis for the inappropriately high 
level expression of the transgene  was shown to be the 
consequence of very high levels of transcription  in the 
epithelial cells of the villi rather than to expression in 
inappropriate cell types. The cis-acting  DNA se- 
quences required for expression of the AFP gene in 
the gut were investigated using Caco-2 cells, a human 
colon adenocarcinoma cell line.  These experiments in- 
dicated that,  with one exception, the regulatory ele- 
ments required in both the promoter and enhancer re- 
gions of the gene coincided with those that are 
necessary for high level expression in the liver. The 
one exception was enhancer II,  located 5 kbp of DNA 
upstream of the gene, which exhibited no activity in 
Caco-2 cells. 
T 
HE gastrointestinal  tract is a complex organ that pro- 
vides an excellent system for studying aspects of cellu- 
lar differentiation  during development.  At day 15 of 
gestation in the fetal rat, the small intestine is a circular layer 
of undifferentiated  stratified  epithelial  cells surrounding  a 
tiny lumen (29). By day 19 of gestation,  this epithelium con- 
verts to the simple columnar type, the lumen expands,  and 
villi are formed (30). Crypts develop between the villi imme- 
diately after birth, and cell proliferation  becomes confined 
to these crypts. The developing crypts are initially polyclonal 
in nature but become monoclonal by the age of 2 wk in the 
mouse (45). 
The crypts and the villi  compartmentalize  the prediffer- 
entiated and differentiated cells of the adult intestinal epithe- 
lium. Stem ceils localized at the base of the crypts give rise 
to proliferative cells that differentiate into at least four differ- 
ent cell types:  villus columnar  cells (enterocytes),  goblet 
cells, enteroendocrine cells, and Paneth  cells (26).  Within 
'~3 d, all of the newly differentiated  cells, except the Paneth 
cells, which remain  at the base of the villi,  migrate  up the 
villi and are extruded at the tip (44). The adult intestinal epi- 
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thelium  is constantly undergoing  rapid renewal to the extent 
that each crypt in the mouse small intestine produces •275 
cells per day (41). 
The marked changes  in cell population that occur in the 
gut during late gestation and early neonatal development are 
accompanied by changes in the synthesis  of et-fetoprotein 
(AFP), I the major serum protein of the mammalian fetus. 
This protein,  which is expressed at high levels in the fetal 
liver and yolk sac, constitutes 0.1% of the total mRNA in the 
fetal gut (50).  At birth, AFP mRNA declines precipitously 
in both liver and gut to levels that are barely detectable (51). 
The decline in liver has been extensively studied and attrib- 
uted to a dominant cis-acting  silencer element that lies be- 
tween the promoter and  three  enhancers  of the gene  (4, 
Vacher, J., and S. Tilghman,  manuscript submitted for publi- 
cation).  In addition,  the adult basal level in liver is deter- 
mined, at least in part, by a trans-acting  locus termed raf, 
for regulation  of AFP (3, 36). 
To understand the basis for the ontogeny of AFP transcrip- 
tion in the gut and to ask whether it is mediated by the same 
positive and negative regulatory elements that govern its ex- 
pression in liver, we investigated the nature of the cells that 
1. Abbreviations used in this paper: AFP, ,a,-fetoprotein; TK, thymidine ki- 
nase; TTP,  ribosylthymine triphosphate. 
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used both transgenic mice and transient expression assays in 
a human colon adenocarcinoma cell line to identify elements 
in the AFP gene that contribute to its expression in the gut. 
Materials and Methods 
Tissue Preparation and Sectioning 
ICR:Ha (icr) mice or mice from the transgenic line 164-6A (21) were killed, 
and intestines  were immediately  dissected. For in situ hybridizations,  tis- 
sues were washed in PBS, blotted dry, and frozen in O.C.T. (Miles Laborato- 
ries Inc., Elkhart, IN) in liquid nitrogen.  8-#m sections were cut on a cryo- 
star, placed on room temperature poly-L-lysine-coated  slides, and stored at 
-70°C.  Immediately before the prehybridization and hybridization steps, 
tissue was thawed and fixed for 2 min in 4% paraformaldehyde  in PBS. For 
immunohistochemistry,  tissues were fixed for 1-2 h in Bouin's fixative and 
paraffin  embedded, and 8-/.tm sections were collected  on poly-L-lysine- 
treated slides. 
Preparation of  Radiolabeled Probes 
A 440-bp Hinc II mouse genomic DNA fragment containing AFP exon  1 
and a 907-bp AFP cDNA clone spanning exons 3-8 were cloned into SP65 
and pGEM 2, respectively.  SP6 or T7 polymerase (Promega Biotec, Madi- 
son, WI) was used to generate 35S-labeled cRNA probes.  A 900-bp Pst I 
fragment from a human cDNA clone (42), a 1.9-kb Pvu II fragment of the 
herpes simplex virus thymidine kinase (TK) gene (31), and a  1.3-kb Hind 
III fragment from the ribosomal protein gene rpL32/4A (13) (provided by 
Dr. Robert Perry, Institute for Cancer Research, Philadelphia, PA) were gel 
purified, and 32p-labeled DNA probes were prepared by nick translation. 
In Situ Hybridizations 
In situ hybridizations were conducted essentially according to the method 
of Cox et al. (12), with some modifications.  Briefly, prehybridization treat- 
ment included rehydration  of tissue and treatment with acetic anhydride 
(0.25 % vol/vol) in 0.1 M trivthanolamine, pH 8.0. After dehydration,  tissues 
were incubated with lO  s cpm [35S] cDNA/#I in 50% formamide, 2x SSC 
(lx SSC is 0.15 M NaC1, 0.015 M Na citrate), 10 mM DTT, 1 mg/ml yeast 
tRNA,  1 mg/ml sheared denatured  salmon sperm DNA,  and 2  mg/ml 
nuclease-free BSA at 55°C overnight. After hybridization, tissue was treated 
with 10 #g/ml RNase A at 37°C  for 30 min to remove any unhybridized 
probe. Sections ware washed at 55°C in 0.1x SSC, 10 mM/3-mercaptoetha- 
nol. Autoradiography  was performed using NTB-2 photographic  emulsion 
(Eastman Kodak Co., Rochester,  NY). 
lmmunohistochemical  Staining 
Immunohistocbemical  studies with rabbit anti-mouse AFP (ICN Biochemi- 
cals, Inc., Irvine, CA) and rabbit anti-bovine chromogranin A (kindly pro- 
vided by Dr. Ruth Angeletti, Albert Einstein College of Medicine, Bronx, 
NY) antibodies were performed using the avidin-biotin technique (23) with 
a Vectastain kit from Vector Laboratories,  Inc. (Burlingame,  CA).  Double 
antibody staining with sheep anti-rat AFP serum (Nordic Immunological 
Laboratories,  Tilburg, The Netherlands) and the chromogranin A antibody 
was visualized by immunofluorescence.  Tissues were treated with a 5:1 mix- 
ture of methanol and peroxide.  Slides were blocked with 0.5 M Tris-HCl, 
pH 7.5, 2% FCS, 2% BSA. AFP and chromogranin A antibodies were used 
in 1:100 dilution. FITC-labeled goat anti-rabbit IgG was purchased from 
Southern Biotechnology  Associates,  Inc. (Birmingham, AL), biotin-conju- 
gated goat anti-sheep IgG was from Vector Laboratories,  Inc., and avidin- 
rhodamine was prepared by Dr. Tim Manser (Princeton University, Prince- 
ton, N  J). 
In Vivo  ~H Labeling 
[3H]ribosylthymine  triphosphate  (TTP)  (Amersham  Corp.,  Arlington 
Heights,  IL) in 50%  ethanol was dried down and resuspended  in 0.85% 
NaC1. ICR:Ha (icr) females at day 19 of pregnancy  were anesthetized with 
avertin and injected via the retinal orbital route with 2-3 #Ci of label per 
gram body weight.  Animals were killed 60-90 min after injection.  Adult 
and fetal intestines were dissected, fixed in Bouin's fixative for 2 h, paraffin 
embedded, and sectioned.  Sections were incubated with rabbit anti-mouse 
AFP antibodies and then dipped  in Eastman Kodak  Co.  NTB-2  photo- 
graphic emulsion. Slides  were exposed  for 16 d. 
Cell Culture and Transient Transfection Assays 
The four human gut cell lines,  LoVo, Caco-2,  Ht-29,  and HuTu 80, were 
obtained from the American Type Culture Collection (Rockville, MD). The 
cells were cultured in BIO-RICH medium containing 10% FCS (Gibeo Lab- 
oratories, Grand Island, NY). The cells were regularly subeultured immedi- 
Figure  1.  In situ hybridizations of 3~S-labeled AFP exon  1 probe to sections of fetal and adult mouse small intestine. Sections of small 
intestine dissected from fetal mice at  19 d  of gestation (A) or from adults at 3--4 wk of age (B and C) were hybridized with 35S-labeled 
907-nucleotide AFP cRNA probe.  Exposures  were  for 4  d.  Bars:  (A and B) 50 #m;  (C) 25 #m. 
The Journal of Cell Biology, Volume 110, 1990  916 Figure 2.  AFP is expressed in a subset of enteroendocrine ceils that express chromogranin A. Small intestines removed from adult mice 
were fixed in Bouin's fixative, paraffin embedded, and sectioned. Sections were incubated with rabbit anti-mouse AFP antibody (A and 
C) or rabbit anti-bovine chromogranin A antibody (B and D), and antibody reactivity was visualized by the biotin-avidin technique. The 
low magnification views (A and B) demonstrate that cells expressing AFP or chromogranin A are found at approximately equal frequency. 
Examples of cells expressing either antigen are denoted by arrows. At higher magnification, a difference in intracellular localization of 
the two antigens can be noted. AFP is generally found distributed throughout the length of the cell (C), while chromogranin A  (D) is 
often found localized toward the basal end. Tissue sections were also incubated with both sheep anti-rat AFP and the rabbit anti-chromo- 
granin antibody. AFP reactivity was detected by incubation with a biotinylated goat anti-sheep secondary antibody and avidin-rhodamine 
(E). Chromogranin A reactivity was detected by incubation with an FITC-conjugated  goat anti-rabbit secondary antibody (F). The differen- 
tial distribution of the two antigens in the same cell can be seen in E and E  Bars: (A and B) 50/~m;  (C-F) 25/~m. 
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line were performed as previously described (17, 19).  In summary, 10 ~g 
of plasmid DNA was added to each plate using the calcium phosphate pre- 
cipitation method. The DNA was left on the cells for 16 h, after which the 
cells were washed in PBS and then harvested at 48 h. RNA was prepared 
using the hot phenol method and enriched for poly (A)  + RNA by oligo 
(dT) cellulose chromatography (2). Poly (A)  + RNAs were electrophoresed 
in a 6% formaldehyde, 1.5% agarose gel in MOPS buffer (20 mM morpho- 
linepropanesulfonic acid, 5 mM sodium acetate, 1 mM EDTA, pH 7.0) after 
heat denaturation at 55°C for 15 rain in 70% formamide, lx MOPS. The 
gel was blotted onto nitrocellulose in 20× SSC, and the filters were hybrid- 
ized in 50%  formamide containing dextran sulfate (49). 
For the isolation of  plasmid DNA from transfected cells, 10 % of the cells 
harvested 48 h after transfection were lysed by the method of Hirt (22). Af- 
ter proteinase K digestion, Hirt supernatants were phenol and chloroform 
extracted and ethanol precipitated. Equivalent portions of each sample were 
digested with restriction enzymes and electrophoresed on 1% agarose gels 
in 40 mM Tris-acetate,  1 mM EDTA, pH 7.2.  Gels were blotted by the 
method of Southern (46)  and hybridized as described (54). 
Nuclear Run-on Assay 
Nuclei were purified from fetal intestines (day  19 of gestation) of ICR:Ha 
(icr) mice and transgenic line 164-6A.  Intestines were homogenized in 10 
mM Tris-HCI, pH 7.4,  10 mM NaCI, 3 mM MgCI2, 0.5% NP-40 (Particle 
Data Inc., EImhurst, IL), 2.75 mM DTT, 20 U/ml RNasin (Promega Bio- 
tee), and 0.25 M sucrose. Tissue homogenate was layered over a 3-ml cush- 
ion of 2.6 M sucrose in homogenization buffer, and nuclei were pelleted by 
centrifugation for 45 min at 25,000 rpm at 0°C. Assays were performed ac- 
cording to Konieczny and Emerson (24). Filters were hybridized in 4x SET 
(1 x  is 150 mM NaCI, 50 mM Tris-Cl, pH 8.0, 5 mM EDTA), 1  x  Denhardt's 
solution (0.02% BSA, 0.02% polyvinyl pyrrolidone 40, 0.02%  Ficoll 400), 
100 mg/ml sheared salmon sperm DNA, and 50% formamide at 42°C. The 
filters were washed three times for 30 min in 0.Ix  SET and 0.1% SDS at 
60°C. 
Results 
Localization of  AFP Transcripts in the Fetal 
and Adult Small Intestine 
It has been demonstrated, both by immunohistochemistry 
(25) and in situ hybridization techniques (14, 40), that AFP 
is synthesized by most hepatocytes in the fetal liver and that 
postnatal repression is accomplished by a uniform diminu- 
tion in its transcription rate in all cells (25, 51). To identify 
the cells that transcribe the AFP gene in the gastrointestinal 
tract, a 35S-labeled cRNA probe was hybridized with cross 
sections of intestine from fetal mice at day 19 of gestation 
(1 d before birth) and of postweaning mice, 3-4 wk of age. 
In the fetus, grains due to hybridization were visible over 
most of the cells lining the villi (Fig. 1 A). After birth, how- 
ever, grains were restricted to single isolated cells along the 
adult villi that continued to express high levels of AFP RNA 
(Fig.  1, B and C). These cells constituted <1% of the total 
cells lining the villi. 
AFP Is Expressed in a Subset of  Enteroendocrine Cells 
in the Adult Small Intestine 
The cells expressing AFP mRNA in the adult gut were dis- 
tributed in a pattern and frequency that suggested that they 
could be of enteroendocrine origin (8, 9). To confirm their 
identity, an antibody against chromogranin A, an acidic gly- 
coprotein that has been used as a marker for the enteroendo- 
crine system, was used (34). Separate sections of adult small 
intestine were incubated with rabbit anti-mouse AFP or rab- 
bit anti-bovine chromogranin A. The pattern and frequency 
of AFP- and chromogranin A-expressing cells in homolo- 
gous sections were very similar (Fig. 2, A and B) but not 
identical in all sections examined. At a higher magnification, 
differences in the intracellular localization of AFP and chro- 
mogranin A could be seen as well. AFP was normally dis- 
tributed evenly throughout the cells, while the chromogranin 
A reactivity was localized more basally (Fig. 2, C and D). 
Double  antibody staining was  conducted with  a  sheep 
anti-rat  AFP  serum  and the  rabbit  anti-bovine chromo- 
granin A antibody to ascertain whether the AFP and chro- 
mogranin A antibodies colocalized to the same cells. The 
two antibodies reacted with the same cells •85  % of  the time, 
indicating that AFP is indeed expressed in enteroendocrine 
cells. An example of the same cell reacting with both anti- 
bodies is shown in Fig. 2, E and E  A subset of cells showed 
positive staining for either AFP or chromogranin A alone. 
Since AFP is presumably secreted by the enteroendocrine 
cells (secretion can be observed in the lamina propria in Fig. 
2 A), the chromogranin A positive and AFP negative cells 
could have been a result of AFP's recent secretion. On the 
other hand, it may be that AFP and chromogranin A  are 
differentially expressed in different subclasses of enteroen- 
docrine cells. 
AFP Transcription Is Not Associated with Cell 
Division in the Gut 
Enteroendocrine cells are present in the fetal gut during late 
gestation, as well as in the adult gut, at approximately the 
same frequency (32, 33). Thus, only a small proportion of 
the cells that transcribe the AFP gene in the fetal gut can be 
of enteroendocrine origin. The identity of the cells that ex- 
press AFP in the fetal gut and their relationship to the well- 
defined cells of the adult gut is not clear. In the case of the 
liver,  it has been established that the fetal hepatocytes that 
transcribe AFP are dividing and that repression in AFP tran- 
scription is coincident with a cessation of DNA synthesis in 
neonatal hepatocytes (51). This suggested to us that a similar 
relationship between AFP transcription and DNA synthesis 
might exist in the gut, in that it had been proposed that the 
cells lining the villi in the fetal gut are mitotically active, un- 
like their counterparts in the adult gut. To ask whether this 
was the case, female ICR:Ha (icr) mice at day 19 of preg- 
nancy were injected with [3H]TTP and killed 60-90  min 
later,  and intestines were removed from both the adults and 
fetuses. Before exposure to photographic emulsion, tissue 
sections were incubated with antibodies against mouse AFP, 
and binding was detected with the biotin-avidin technique. 
In the fetal gut,  the cells that had incorporated pH]TTP 
were localized to the base of the villi where crypt formation 
would occur after birth (Fig. 3 B). These cells did not stain 
with AFP antibodies (see arrows in Fig. 3, A and B). Rather, 
the AFP antibodies reacted in a diffuse manner to nascent villi 
(Fig. 3 A), consistent with the pattern of RNA localization 
observed for the in situ hybridization experiments (Fig. 1 A). 
The distribution of dividing cells in the day 19 fetus is highly 
reminiscent of the pattern of incorporation of [3H]TTP la- 
bel observed in the adult gut (Fig. 3,  C and D). From this 
we conclude that the expression of AFP in the cells lining 
the fetal villi is not correlated with mitotic activity. 
Postnatal Repression of  AFP Transcription Is Not raf 
Regulated in the Gastrointestinal Tract 
The basal level of AFP mRNA in the postpartum mouse liver 
The Journal  of Cell Biology,  Volume 110, 1990  918 Figure 3. AFP is not expressed in the proliferating cells of the fetus or adult.  Mice at 19 d of pregnancy were injected with 2-3 #Ci of 
[3H]dTTP per gram of body weight and killed 60-90 min later. The intestines of the fetuses and adult females were fixed in Bouin's fixa- 
tive, paraffin embedded,  and sectioned.  Sections were incubated with an anti-mouse AFP antibody, and reactivity was visualized by the 
avidin-biotin method (23). Sections were then exposed to photographic emulsion for 17 d. Brightfield and darkfield views of the fetal gut 
(A and B) and adult gut (C and D) are shown. Diffuse AFP staining can be seen along the nascent villi of the fetus (A), but grains indicating 
cell division are localized to the rudimentary  crypts as can be clearly  seen in the darkfield view (B). In the adult,  a few cells denoted 
by arrows in C strongly react with AFP antibody. The peroxidase reaction product deflects light in the darkfield view, and, although no 
3H grains are visible above these cells, they appear bright in D. Cell division is localized primarily to the crypts in the adult animals (D). 
Bars, 50 #m. 
is regulated in part by a genetically defined trans-acting locus 
named  raf,  for regulation  of AFP.  Two alleles  have been 
identified  for  the  raf locus,  raft  and  rafb  (36).  BALB/cJ 
mice are homozygous for the rare recessive raf  ~ allele, re- 
sulting in lO-15-fold higher basal level AFP transcription in 
livers of adult BALB/cJ mice (3). To determine if rafaffects 
the postpartum repression of AFP transcription in the gut, 
poly (A)  ÷ RNA was isolated from the gastrointestinal tracts 
of BALB/cJ mice (raj~/rafb) and C3H/HeJ mice (rafa/rafo) 
at different times before and after birth (Fig. 4).  At day 19 
of gestation, relatively high levels of AFP mRNA could be 
detected in both strains,  and no differences were observed 
as the RNA levels dropped rapidly after birth. Thus, the raf 
gene does not appear to affect the repression of AFP mRNA 
in the gut. 
AFP Is Expressed in the Human Gut Cell Line Caco-2 
To investigate the cis-acting  elements that are necessary for 
transcription of the AFP gene in the gut, we first identified 
a gut cell line that could be an appropriate recipient for gene 
transfer experiments. RNA was isolated from three cell lines 
derived from human colon adenocarcinomas, LoVo, Caco-2, 
and Ht-29 (not shown), and one line derived from an adeno- 
carcinoma of the duodenum,  HuTu 80.  These RNAs were 
subjected to electrophoresis through a denaturing gel, blot- 
ted to nitrocellulose,  and hybridized with an AFP-specific 
probe (Fig.  5).  Only the  Caco-2 cell  line expressed AFP 
mRNA. The level of AFP RNA expressed in Caco-2 cells 
was comparable with that in Hep3B hepatoma cells, but sig- 
nificantly  less than  in  another human  hepatoma cell  line, 
HepG2. 
AFP Enhancers I and III Are Active in Caco-2 Cells 
The expression of the AFP gene in liver cells has been attrib- 
uted to the action of three cellular enhancers located 2.5, 5.0, 
and 6.5 kbp of DNA upstream of the transcriptional start site 
Tyner et al. AFP Gene Expression  in the Mouse Gastrointestinal  Tract  919 lqgure 4. AFP expression in the gut is not rafregulated. Poly (A)  ÷ 
RNAs were  isolated from the  intestines  of BALBc/J (raft~raft) 
and C3H/HeJ (raf°/raf  a) mice at day  19 of gestation  (lane  -1 ) 
and 2, 4, 8, and 14 d after birth (lanes 2, 4, 8, and 14, respectively). 
10 ~g of each sample was electrophoresed through a 1.5 % agarose 
formaldehyde gel and transferred to nitrocellulose by blotting. Blots 
were hybridized with a 907-bp 32p-labeled AFP cDNA probe. Ex- 
posure time was 1 wk, except for day 14 which was exposed for 3 wk. 
hancement in Caco-2 cells whether it was assayed as a 2.25- 
kb Eco RI-Bam H1  fragment or a  380-bp minimal region 
(Fig.  6, A, lanes 10 and//).  This level was consistent with 
its activity in liver cells (18).  Thus, the major difference in 
the behavior of the three enhancers in liver and gut cells is 
the absence of activity of enhancer II. 
An HNF-1 Binding Site in the AFP Promoter Is 
Required for E~cient Transcription in Caco-2 Cells 
The functional domains of the promoter of the AFP gene in 
liver have been studied extensively in both the rat and the 
mouse genes (15, 17, 20).  These studies have identified two 
binding sites for the transcription factor HNF-1, one centered 
at  -50 bp and the other at  -110 bp. This factor was origi- 
nally identified as a liver-specific transcription factor that in- 
teracts with the promoters of a variety of genes transcribed 
in the liver (6,  10,  11, 27). It was recently demonstrated that 
HNF-1 binding to the mouse AFP promoter at  -110 bp is 
essential for its tissue-specific transcription in human hep- 
atoma cells (15),  and it can be inferred that binding down- 
stream at  -50 bp is also crucial for the activity of the rat 
AFP gene promoter (11, 20). 
(17, 56). The three enhancers, which were each localized to 
200-300 bp segments of DNA, exhibited nonadditive, equiv- 
alent activities when tested by transient transfection into hu- 
man hepatoma cells. To examine the activities of these en- 
hancers in Caco-2 cells, segments of DNA containing them 
were ligated to the herpes simplex virus TK gene and 200 
bp of its promoter. These were introduced as calcium phos- 
phate precipitates  into Caco-2 cells,  and,  48  h  later,  cells 
were harvested and RNA and Hirt DNA were prepared. The 
levels of TK transcription were determined by Northern gel 
analysis,  using  a  hybridization  probe  internal  to  the  TK 
structural gene. The blots were also hybridized to a ribosom- 
al protein L32 probe to control for loading of RNA onto the 
gels. To control for transfection efficiency, the concentration 
of episomal TK plasmid in Hirt extracts was monitored. The 
experimental results of the transfections are shown in Fig. 6 
A, with the gel lanes corresponding to the constructs as num- 
bered in the diagram (Fig.  6 B). 
Enhancer I was originally defined as a Bam H1 fragment 
spanning from -1.0 to  -3.9 kb upstream of the AFP gene 
cap site. As shown in Fig. 6 A, lane 2, it enhanced transcrip- 
tion of the TK gene alone (lane/) ,'~20-fold. When the mini- 
mal region of 308 bp (MER I; see 18) required for full en- 
hancer I function in liver cells was tested in Caco-2 (lane 3), 
a  similar degree of enhancement was observed. Therefore, 
enhancing activity in enhancer I  localized to the same se- 
quence in both liver and gut cells.  This conclusion is rein- 
forced by the behavior of a duplication ofa 195-bp subregion 
of MER I, which produced a 20-fold stimulation of transcrip- 
tion in liver cells (18)  as well as in Caco-2 cells (lane 4). 
In contrast to enhancer I, enhancer II exhibited no activity 
in Caco-2 cells, whether tested as a 1.5-kb Barn HI fragment 
(lanes 5 and 6) or as a  181- (lane 7) or a 420-bp (lanes 8 and 
9) minimal region. All these constructs exhibited 15-30-fold 
enhancing activity in hepatoma cells (18).  Finally, enhancer 
III behaved in an intermediate manner, showing a 10-fold en- 
Figure  5. Expression of  human AFP mRNA in colon carcinoma cell 
lines. Poly (A)  + RNA was isolated from three human cell lines de- 
rived from the gut and two cell lines derived from human hepato- 
mas. 4 #g of each RNA was electrophoresed  through a 1.5 % agar- 
ose gel in formaldehyde and transferred onto a nitrocellulose filter. 
The filter was hybridized with a human AFP cDNA fragment, the 
probe was washed off, and the blot was rehybridized to a labeled 
fragment derived from the mouse rpL32 gene (13). 
The Journal of Cell Biology, Volume 110, 1990  920 Figure 6. Functional  analysis of  the AFP 
enhancers in Caco-2 cells. Different seg- 
ments of the 5' flanking region of the 
mouse AFP gene (top line in B) that had 
been previously shown to contain liver- 
specific enhancer function (18) were ii- 
gated to the TK gene, along with its pro- 
moter  (construct  1  in B).  These  seg- 
ments were a Bam HI fragment from -1 
to  -3.9 kb (enhancer I; construct 2); a 
308-bp subfragment of it that contained 
all enhancer I  activity (construct 3);  a 
duplication of 195 bp of the 3' end of the 
subfragment (construct 4);  a  Bam  H1 
fragment  from  -3.9  to  -5.4  kb  (en- 
hancer II; constructs 5 and 6; two orien- 
tations); a 181-bp  subfragment of enhancer 
II (construct 7); a 420-bp subfragment 
in enhancer II that contains all of its ac- 
tivity in liver ceils (constructs 8 and 9; 
two  orientations); an Eco  R1-Bam H1 
fragment that spans -5.4 to -7.6 kb (en- 
hancer III; construct 10); and a 380-bp 
subfragment of enhancer HI that contains 
all its activity in liver cells  (construct 
11). All of these constructs are described 
in detail (18). These constructs were in- 
troduced  into Caco-2  cells,  and  RNA 
and Hirt DNA were prepared 48 h later. 
The  poly  (A)  +  RNA  was  electropho- 
resed through a  1.5%  agarose  gel and 
transferred  to  nitrocellulose, and blots 
were  probed  with  a  1.9-kb  fragment 
containing the TK structural gene (31), 
stripped, and rehybridized to rpL32 gene 
fragment (13).  The Hirt DNA prepara- 
tions were digested with Pst I and elec- 
trophoresed through a 1.0% agarose gel, 
transferred to nitrocellulose, and hybrid- 
ized to an 800-bp DNA fragment from 
within TK structural gene. The lanes in 
A are numbered according to the con- 
structs diagrammed in B. 
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gut, transcription of the TK structural gene under the direc- 
tion of varying segments of the AFP promoter was monitored 
in Caco-2 cells. Fig. 7 depicts the results of these transfection 
experiments, along with a diagram indicating the constructs 
used.  The level of transcription directed by 250 bp of the 
AFP promoter was comparable with that of the TK promoter 
alone (Fig. 7, lanes 2 and 4). This level of transcription de- 
creased substantially when the distal HNF-I was disrupted 
by a deletion to  -118 bp (lane 3).  Introduction of a 3-base 
substitution and 1-base deletion in this HNF-1 site resulted in 
an equivalent decrease in transcription in Caco-2 cells (lanes 
6 and 6'), further suggesting that the HNF-1 site at -110 bp 
plays an important role in gut-specific transcription. 
Interestingly,  the  addition  of sequences  extending  from 
-250 to -1,000 bp resulted in a decrease in transcription in 
gut ceils, a result that was not observed in liver cells (17). 
This suggests that sequences upstream of the promoter may 
play a role in negatively modulating the transcription rate of 
the gene in the gut cells. This region contains the dominant 
acting silencer that is necessary and sufficient for repression 
of the AFP gene in liver after birth (Vacher, J., and S. Tilgh- 
man, manuscript submitted for publication). 
Figure 7. Functional analysis of the AFP gene promoter in Caco-2 
cells. Segments of the AFP promoter (indicated by the dark line), 
which share a 3' endpoint at +1 and 5' endpoints indicated in the 
figure, were linked to the cap site of the TK structural gene (con- 
structs 3-6). In construct  6, four base changes were made in an 
HNF-1 site between  -120 and  -100, as indicated by the break in 
the dark line. These were transfected, as was the TK gene driven 
by 200 bp of its own promoter region (construct 2) or the TK gene 
and promoter linked to enhancer I of the AFP gene (construct 1 ) 
into Caco-2 cells. 48 h later RNA and Hirt DNA were analyzed as 
described in the legend to Fig. 6. The lanes of the gel are numbered 
according to the numbers of the constructs below. Lanes 6 and 6' 
represent two different transfections of construct  6. 
An Overexpressed AFP Transgene Is Expressed in the 
Same Cells as the Endogenous AFP Gene in the Fetal 
and Adult Gut 
The elements responsible for AFP gene expression in vivo 
have been examined using the microinjection of genes into 
the mouse zygote (21). One of the most surprising results to 
come from these studies was the observation that a transgene 
consisting of 6.6 kb of 5' flanking DNA, including the three 
cellular enhancers and the tissue-specific promoter, linked to 
an internally deleted AFP "minigene" consisting of the first 
3 and the last 2 exons of the 15-exon gene, was expressed at 
an inappropriately high level in the fetal gut. That is, inde- 
pendent of the copy number of the transgene in the mouse 
germline or its site of integration, transgenic mice expressed 
many-fold more AFP minigene RNA than endogenous AFP 
mRNA  in  the  fetal gut.  Two  explanations  were  contem- 
plated. First, it was possible that the overexpression was the 
consequence of inappropriate expression in the wrong cell 
types in the gut.  Second, it was possible that the transgene 
transcript was selectively stabilized in the fetal gut, relative 
to the other expressing tissues in the mouse. 
To examine these possibilities, a 35S-labeled  AFP exon 1 
probe was hybridized  to  tissue  sections  from one  line  of 
transgenic mice (164-6A) overexpressing the AFP minigene. 
The exon 1 probe will hybridize with equal affinity to the en- 
dogenous and transgene transcripts,  but because of the ex- 
traordinary  levels  of  the  transgene  transcripts,  and  the 
Figure 8. Transgenic mice overexpressing an AFP minigene maintain appropriate cell type expression of the transgene. Transgenic mice 
(line 164-6A) containing 6.6 kb of 5' AFP upstream sequence linked to an AFP minigene consisting of the first two and last three exons 
of the AFP gene greatly overexpress the minigene in the fetal gut. Sections of fetal gut at day 19 of gestation (A and B; brightfield and 
darkfield views, respectively), at 2 wk postpartum (C), and at adulthood (D) were hybridized with a 35S-labeled 440-nucleotide AFP exon 
1 cRNA probe. This probe contains only 129 nucleotides of coding sequence and will hybridize equally with both the endogenous AFP 
gene transcripts and the minigene transcripts. Exposures were for 2 d. In the fetus, a dense concentration of grains can be visualized along 
the villi in darkfield (B). In the postpartum transgenic animal (C and D), single cells appearing at the same frequency as the enteroendocrine 
cells are found to express the transgene product.  Bars, 50/zm. 
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minigene in the transgenic mice occurs at the 
transcriptional level. Purified nuclei from fetal 
intestines from ICR:Ha  (icr)  and  transgenic 
164-6A mice were incubated with a nucleotide 
mix containing [32p]UTP.  Radiolabeled RNA 
was extracted from the nuclei and hybridized 
with filters containing 10 ttg of each of the fol- 
lowing DNAs: AFP exon 1; AFP exons 3-8; 
HI9, a gene expressed at high levels in the fetal 
gastrointestinal tract; actin; and pUCIS. 
shorter exposure times used, the probe detects primarily the 
transgene  product.  After  autoradiography,  sections  were 
stained with hematoxylin and eosin. In Fig. 8, A and B, sec- 
tions of fetal gut are viewed under brightfield and darldield 
microscopy, and  it is clear that although the transgene is 
overexpressed ,x,50-fold in this line (21), the transcripts are 
restricted to the appropriate cells lining the villi. In the post- 
partum animal at 2 wk of  age (Fig. 8 C) and in the adult (Fig. 
8 D) expression is restricted to single cells. 
The high level of  expression of  the transgene was examined 
by nuclear run-on experiments to determine whether it was 
the consequence of increased transcription or stabilization of 
the transcript.  Nuclei were prepared from fetal transgenic 
and nontransgenie animals and incubated for a short period 
of time in the presence of pep]uTP. The radioactive tran- 
scripts were hybridized with filters onto which plasmid DNA 
containing AFP exon 1 DNA, and DNA encoding AFP ex- 
ons 3-8 was immobilized. The exon 1 DNA will hybridize 
with both the transgene product and the endogenous gene 
product, while exons 3-8 will hybridize only with the endog- 
enous gene product. As shown in Fig. 9, transcripts homolo- 
gous to AFP exon 1 were detected at high levels in the trans- 
genie progeny but not in the nontransgenic animals, leading 
to the conclusion that the overexpression arises from high 
level transcription of the transgene in the appropriate cell 
types. 
Discussion 
Localization of  AFP-producing Cells in the Gut 
These studies present the first detailed description of the on- 
togeny of AFP gene expression in the gastrointestinal tract. 
AFP synthesis had previously been localized to the endoder- 
mal cells of the visceral yolk sac (14) and to all hepatocytes 
of the fetal liver (25, 40). By using in situ hybridization to 
tissue sections, we demonstrated that AFP is expressed in 
most epithelial ceils lining the villi of the fetal gut, but after 
birth it becomes restricted to a subpopulation of enteroendo- 
crine cells. Sweetser et al. (48) have also noted a strikingly 
high level of expression in enteroendocrine cells of another 
endoderm-specific gene, that encoding liver fatty acid bind- 
ing protein. However, unlike AFP, the fatty acid binding pro- 
tein is also expressed in adult enterocytes, in a horizontal gra- 
dient that is highest in the proximal duodenum and lowest in 
the colon. 
The cells transcribing the AFP gene in the fetal gut are a 
mixture of immature enterocytes and goblet and enteroendo- 
crine cells. Enteroendocrine cells have been detected by day 
19 of gestation in the rat intestine, 3 d before birth (30), and 
in the human as early as  12 wk of gestation (32). We also 
observed distinct staining of cells with the ehromogranin A 
antibody at day 19 of gestation in the mouse, suggesting the 
presence of differentiated endocrine cells at this stage.  How- 
ever, their frequency was not significantly different from that 
in the adult gut, arguing that the global AFP transcription 
in the fetal gut cannot be attributed to a more prevalent distri- 
bution of these cells alone. 
There are more than 15 different classes of endocrine cells 
in the gastrointestinal tract, distinguishable by different mor- 
phological characteristics of their secretory granules and by 
the  different products they secrete (for a  review see 47). 
Chromogranin A, a large acidic glyeoprotein with no known 
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these endocrine cells and is stored along with a variety of 
polypeptide hormones (1, 28,  35).  At the present time, we 
do not know the nature of the peptide hormones that are co- 
expressed with AFP and chromogranin A. AFP is a soluble 
glycoprotein that has the ability to bind many ligands includ- 
ing fatty acids, metals, steroids (estrogens), thyroxin, and 
tryptophan (38,  50).  Although the function of AFP is un- 
known, further characterization of its expression in entero- 
endocrine cells may help us discern a function in the gas- 
trointestinal tract. 
Thus, two distinct patterns ofAFP gene expression coexist 
in cells derived from a common precursor stem cell in the 
adult gut; in the majority of cells the AFP gene is repressed, 
however, in a subset of enteroendocrine cells it continues to 
be transcribed at a  rate that approximates that in the fetal 
cells. Unlike the liver, where there is a strict correlation be- 
tween DNA synthesis and AFP gene transcription, the cessa- 
tion of AFP transcription in the gut after birth cannot be at- 
tributed to a  decrease in the number of mitotically active 
cells. This conclusion arose from our observation that DNA 
synthesis is restricted to the rudimentary crypts before the 
loss of AFP transcripts along the villi in the day 19 fetus. 
Transcriptional Control of the AFP Gene in the Gut 
AFP is transcribed in the developing mouse in multiple cell 
types, all of endodermal origin. That these cell types might 
respond differently to the regulatory regions of the gene was 
first suggested by experiments whereby the gene was reintro- 
duced into the mouse germline as an internally deleted mini- 
gene (21). The presence of all three enhancers of the gene 
generated high level, tissue-specific transcription in the vis- 
ceral endoderm of the yolk sac, the liver, and gut. However, 
when the enhancers were tested separately, it was observed 
that each had a unique tissue specificity. Enhancer I activated 
transcription of the minigene in all three tissues, enhancer 
II activated transcription in liver and visceral endoderm, and 
enhancer III only activated transcription in the visceral endo- 
derm (21). We postulated that this differential activity of the 
three enhancers played an important role in determining the 
different levels of expression of the gene, with the highest 
levels in the yolk sac resulting from the activity of all three 
enhancers in that tissue and conversely the low level in the 
gut the consequence of the activity of only one of the en- 
hancers. 
The importance of enhancer I in gut-specific transcription 
was reinforced by the transfection experiments performed in 
this study. Of the three enhancers tested, enhancer I exhib- 
ited the highest activity, enhancer II had no activity, and en- 
hancer  HI enhanced TK transcription to an  intermediate 
level. Based on the results of the transgenic experiments, the 
activity of enhancer III in the Caco-2 cell line was unex- 
pected. This suggests that the minigene, activated only by en- 
hancer III, might be susceptible to position effects due to the 
heterologous sites of integration in vivo. In the transgenic ex- 
periments, enhancer III was assayed as a 1.25-kb Cla I-Barn 
H1 fragment, and, although the minimal region for expres- 
sion in vitro is intact in this sequence, it is also possible that 
additional sequence is required for enhancer UI activity in 
vivo. The transfection experiments demonstrated that the en- 
hancers that were originally identified using liver-derived 
cell lines could account entirely for the enhancer activities 
in Caco-2 cells. 
The failure of enhancer II to activate transcription in either 
transgenic mice or Caco-2 cells needs to be reconciled with 
its strong hypersensitivity to DNAse I in the chromatin of fe- 
tal gut (16). This hypersensitivity could arise from the bind- 
ing of a subset of proteins necessary to activate enhancer II 
or it could suggest a role for enhancer II that has not been 
apparent from the experiments we have performed. 
The analysis of cis-acting elements necessary to activate 
the AFP gene promoter in Caco-2 cells revealed few differ- 
ences between liver- and gut-specific domains. Although the 
trans-acting factor HNF-1  has  only been associated with 
liver-specific transcription to date, we have demonstrated the 
necessity of the HNF-1 binding site at -110 bp for efficient 
transcription of AFP in a gut cell line. In fact, the effect of 
removing the HNF-1 site at -110 bp had a far more profound 
effect on transcription in Caco-2 cells than in liver cells, 
where the loss in the HNF-1 site resulted in a three- to five- 
fold reduction in TK transcription (15).  This is consistent 
with experiments in transgenic mice, where a deletion of a 
portion of the HNF-1  site had a minor effect on liver gene 
expression but completely abolished AFP synthesis in the fe- 
tal gut (Vacher, J., and S. Tilghman, manuscript submitted 
for publication). Hepatocytes and the epithelial cells of the 
gut are both derived from the embryonic foregut. Indeed, 
many genes that are expressed in the liver are also expressed 
in the small intestine (liver fatty acid binding protein, AFP, 
glutamate dehydrogenase, apolipoproteins).  It is therefore 
not surprising that both of  these organs would share common 
regulatory motifs. 
One difference in the behavior of the AFP gene promoter 
in liver and gut cell lines was the repressive effects of se- 
quences  between  -250  and  -1,000  bp  in  Caco-2  cells. 
Within this region is a dominant cis-acting silencer of AFP 
transcription in neonatal liver (Vacher, J., and S. Tilghman, 
manuscript submitted for publication). It is possible that the 
negative effects we observe in Caco-2 cells are the conse- 
quence of the same sequence acting as a negative regulator 
in gut cells. Further experiments in this cell line, as well as 
in vivo,  will be necessary to clarify this point. 
Although the experiments described here and elsewhere 
(5, 15, 17, 18, 20, 21, 43, 55, 56) have shed considerable light 
on the acquisition of tissue specificity of the AFP gene, we 
still do not understand what determines the rate of transcrip- 
tion in each cell type. For example, why is the rate of tran- 
scription in liver and yolk sac ,x,100-fold more than in the 
gut? The striking overexpression of the AFP minigene in the 
gastrointestinal tract of fetal transgenic mice served to high- 
light this interesting problem. The overexpression depends 
upon the presence of enhancer I (21) and the HNF-1 site in 
the promoter (Vacher, J., and S. Tilghman, manuscript sub- 
mitted for publication) since deletion of either abolishes the 
high level expression. In this report, we have shown that the 
overexpression is the consequence of significantly higher 
rates of transcription of the transgene in the correct cells of 
the fetal animal, and not due to ectopic expression, or selec- 
tive stabilization of the minigene in the gut. Yet despite the 
high level expression in the fetus, the transgene is regulated 
appropriately and is repressed in all but the enteroendocrine 
cells of the adult small intestine. 
The rapid loss of AFP transcription in the majority of neo- 
natal villus cells could occur by the absence of positive tran- 
scription factors or the imposition of a dominant negative 
mechanism, such as the one that underlies the repression in 
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mired for publication). Whatever the mechanism, it does not 
appear to be affected by raf, a regulatory  locus that had been 
previously been shown to affect the adult basal level of AFP 
mRNA in the liver. This conclusion arose from an examina- 
tion of the levels of AFP mRNA in the guts of inbred mouse 
strains harboring different alleles of raf Although the prod- 
uct of the raf locus was found to act in a cell autonomous 
manner in the liver (53), this result did not exclude the possi- 
bility that rafwas affecting transcription  in other tissues. It 
must be kept in mind that only two alleles of raf have been 
identified to date, and therefore it is possible that the effect 
of the rare raf  ~  allele in BALB/cJ mice is liver specific and 
that examination of other alleles would reveal effects in the 
gut as well. However, this seems unlikely given that another 
gene, H19 (37), has been shown to be under raf regulation 
in the liver but not in any other tissues in which its expression 
has been examined. 
It is possible that the Caco-2 cell line may provide a useful 
model for understanding the late fetal maturation of the AFP- 
producing cells since it can undergo spontaneous differentia- 
tion in vitro.  Differentiation of these cells, which is accom- 
panied by cell polarization, the formation of tight junctions 
and apical microvilli, and the expression of brush border en- 
zymes and apolipoproteins (7, 39), occurs in a growth rate- 
dependent manner and is particularly  evident at postconflu- 
ent stages.  We have recently observed that this differentiation 
is  accompanied  by  a  significant  increase  in AFP  mRNA 
(Tyner,  A.,  unpublished observations),  suggesting that the 
cells are mimicking late fetal  development rather than the 
postnatal  period when AFP transcription  is repressed.  We 
are currently  investigating  the molecular basis  for the  in- 
crease in AFP transcription  in differentiated  Caco-2 cells. 
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